Communication from the Ministry of Health No. 278 / 2014 Coll.
Communication from the Ministry of Health on the antigenic composition of vaccines for regular, special and exceptional vaccination for 2015
Valid
Communication
Text versions:
28.11.2014
278
COMMUNICATION
Ministry of Health
of 20 November 2014
on the antigenic composition of vaccines for regular, special and emergency vaccination for 2015
The Ministry of Health pursuant to § 80 (1) (e) of Act No. 258 / 2000 Coll., on the Protection of Public Health and on the amendment of certain related acts, as amended, provides for the antigenic composition of vaccines for regular, special and exceptional vaccination for 2015 on the basis of recommendations from the National Immunisation Commission:
1. Antigenic composition of vaccines for periodic vaccination
(1a) a combined diphtheria vaccine, an acellular cough, tetanus, polio (inactivated form), hepatitis B viral, Haemophilus influenzae type b (DTaPHibVHBIPV):
Pertussis toxoid
Pertussis haemagglutinum filamentosum
Pertussis membranae
Diphtheria toxoid
Tetanus toxoid min.
Hepatitis B surface antigen
Inactivated type 1 poliomyelitis virus
Inactivated type 2 poliomyelitis virus
Inactivated type 3 poliomyelitis virus
Lyophilisate Hib: Polyribosylribitol phosphate Haemophilus influenzae b, Tetani toxoid
OR
1aa) a combined diphtheria vaccine, an acellular cough, tetanus, polio (inactivated form), hepatitis B viral, Haemophilus influenzae type b (DTaPHibVHBIPV)
Diphtheria toxoid
Tetanus toxoid
Bordetella pertussis antigens
Pertussis toxoid
Haemagglutinum filamentosum
Poliomyelitidis virus (inactivated)
Type 1 (Mahoney)
Type 2 (MEF-1)
Type 3 (Saukett)
Hepatitis B surface antigen
Haemophilus influenzae type b polysaccharide
(Polyribosylribitol phasphas)
conjugata cum tetani atoxin
(1b) diphtheria, coughs (acellular form), tetanus (DTaP) vaccine:
Diphtheria toxoid ≥ 30 international units
Tetanus toxoid ≥ 40 international units
Pertussis toxoid (PT) 25 micrograms
Pertussis haemagglutinin Filamentosum (FHA) 25 micrograms
Pertactin (69kD) 8 micrograms
1c) Diphtheria vaccine, coughs (acellular form), tetanus, influenza b infection (DTaPHib):
| Diphtheriae anatoxinum | min. 30 mezinárodních jednotek |
| Tetani anatoxinum | min. 40 mezinárodních jednotek |
| Pertussis anatoxinum (PT) | 25 mikrogramů |
| Pertussis haemaglutininum filamentosum | (FHA) 25 mikrogramů |
| Pertactinum (69kD) | 8 mikrogramů |
| Haemophilus influenzae B | 10 mikrogramů |
| cum anatoxino tetanico | 20-40 mikrogramů |
1d) Haemophilus influenzae type b:
1 dose of lyophilised vaccine contains: polysaccharide Hib Purificatum (10 micrograms) cum Anatoxin tetanico (approximately 25 micrograms).
(e) tetanus vaccine:
| Tetani anatoxinum ..... | min. 40 mezinárodních jednotek |
1f) Viral hepatitis B vaccine up to 15 years of age:
| Antigenum tegiminis hepatitidis B | 10 mikrogramů |
1g) vaccine against viral hepatitis B from 16 years of age and above:
| Antigenum tegiminis hepatitidis B | 20 mikrogramů |
(1h) measles, mumps and rubella vaccine:
| Morbillorum virus attenuatum (Schwarz) | min. 103,0 infekční dávka pro buněčnou kulturu50 |
| Parotitidis virus attenuatum (RIT 4385) | min. 103,7 infekční dávka pro buněčnou kulturu50 |
| Rubeolae virus attenuatum (Wistar RA 27/3) | min. 103,0 infekční dávka pro buněčnou kulturu50 |
1ch) an anti-polio vaccine in inactivated form:
| Virus poliomyelitis inactivatum typus 1 (Mahoney) | 40 antigenních D jednotek* |
| Virus poliomyelitis inactivatum typus 2 (MEF-1) | 8 antigenních D jednotek* |
| Virus poliomyelitis inactivatum typus 3 (Saukett) | 32 antigenních D jednotek* |
1i) Streptococcus pneumoniae vaccine in polysaccharide formula:
Polysaccharide Streptococci pneumoniae type:
| 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, 33F ..... | 25 mikrogramů z každého sérotypu |
(j) a vaccine conjugated against pneumococcal infections:
Pneumococcal polysaccharide serotype 1
Pneumococcal polysaccharide serotype 3
Pneumococcal polysaccharide serotype 4
Pneumococcal polysaccharide serotype 5
Pneumococcal polysaccharide serotype 6A
Pneumococcal polysaccharide serotype 6B
Pneumococcal polysaccharide serotype 7F
Pneumococcal polysaccharide serotype 9V
Pneumococcal polysaccharide serotype 14
Pneumococcal polysaccharide serotype 18C
Pneumococcal polysaccharide serotype 19A
Pneumococcal polysaccharide serotype 19F
Pneumococcal polysaccharide serotype 23F
1ka) diphtheria vaccine, coughs (acellular form), tetanus, polio (inactivated form):
| Diphtheriae anatoxinum | ne méně než 2 mezinárodní jednotky |
| Tetani anatoxinum | ne méně než 20 mezinárodních jednotek |
| Pertusové antigeny: | |
| Pertussis anatoxinum | 8 mikrogramů |
| Pertussis haemagglutinum filamentosum | 8 mikrogramů |
| Pertaktin | 2,5 mikrogramů |
| Virus poliomyelitidis inactivatum: | |
| typus 1 (kmen Mahoney) | 40 D jednotek antigenu |
| typus 2 (kmen MEF-1) | 8 D jednotek antigenu |
| typus 3 (kmen Saukett) | 32 D jednotek antigenu |
OR
1kb) diphtheria vaccine, coughs (acellular form), tetanus, polio communicable to children (inactivated form):
| Difterický toxoid | více nebo rovno 2 mezinárodní jednotky (2 Lf) | |
| Tetanický toxoid | více nebo rovno 20 mezinárodních jednotek (5 Lf) | |
| Pertusové antigeny: | ||
| Pertusový toxoid | 2,5 mikrogramů | |
| Filamentózní hemaglutinin | 5 mikrogramů | |
| Fimbrie typu 2+3 | 5 mikrogramů | |
| Pertaktin | 3 mikrogramy | |
| Virus poliomyelitis typu 1 (inaktivovaný) | 40 antigenních D jednotek | |
| Virus poliomyelitis typu 2 (inaktivovaný) | 8 antigenních D jednotek | |
| Virus poliomyelitis typu 3 (inaktivovaný) | 32 antigenních D jednotek | |
1l) tuberculosis vaccine:
| Mycobacterium bovis attenautum (BCG) stratus Danisuc 1331 ≥ 2,0 x 106 ≤ 8,0 x 106 CFU (živých zárodků) | 0,75 mg |
1m) Hepatitis B viral vaccine for persons included in the dialysis programme:
Hepatitis B surface antigen 20 micrograms; adjuvant AS04C containing 3-O-deacyl-4-monophosphoryl lipid A (MPL) 50 micrograms per dose
2. Antigenic composition of vaccines for specific vaccination
2a) Hepatitis B viral vaccine in adult formula:
| Antigenum tegiminis hepatitidis B | 20 mikrogramů |
(2b) rabies vaccine:
Rabiei inactivated virus (Wistar rabies PM / WI strain 38 1503- 3M more than or equal to 2,5 international units per dose (0,5 ml)
2c) Viral hepatitis vaccine And in the adult formula:
Hepatitis A Inactivated Virus
3. Antigenic composition of vaccines for emergency vaccination
3a) Viral hepatitis vaccine And in the adult formula:
Hepatitis A Inactivated Virus
3b. Viral hepatitis vaccine And in the formula for children:
Hepatitis A virus inactivated
In 2015, in view of the planned amendment to Decree No. 537 / 2006 Coll., on vaccination against infectious diseases, a possible modification of the antigenic composition of vaccines for regular vaccination cannot be excluded by publishing the new antigenic composition of these vaccines in the Collection of Laws.
Minister:
MUDr.
Sign in for notes, favorites and notifications
Regulation Information
| Citation | Communication from the Ministry of Health No. 278 / 2014 Coll., on the antigenic composition of vaccines for regular, special and exceptional vaccinations for 2015 |
|---|---|
| Regulation Type | Communication |
| Author | - |
| Collection | Code of Laws |
| Date of Promulgation | 28.11.2014 |
|---|---|
| Effective from | - |
| Effective until | - |
| Status | Valid |
Legal Areas:
Administrative law
Health
The regulation text is for informational purposes only.
Comments 0